Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

The antibody is to treat adult recurrent or metastatic non-keratinising nasopharyngeal carcinoma (NPC) in conjunction with ...

Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

FINISHING a 15-minute sun-bed top-up, Vicky Quait, 55, gives a sigh of satisfaction.  It’s her final session before her ...

Surgeons at Mass Eye and Ear in Boston have found a creative way to make their skin cancer patients look good as new. Our ...

The “Real Housewives of Beverly Hills” star recently revealed that her dad has planned her funeral as her melanoma has spread to her lungs and brain. The Post got the run-down on the deadly skin ...

"We desperately need the funding for head and neck cancer, for all people who need prostheses," she said. Photo shows Mark looks at himself in a mirror and adjusts his nose while wearing a blue ...

S, Principal Investigator at A*STAR SRL are co-authors of the study. While the current study focuses on basal cell carcinoma (BCC), researchers believe the technology could also be adapted to ...

Immunotherapies treat cancer by speeding up tumor cell death, and treat autoimmune disorders—in which the body's immune system attacks its own cells—by tamping down such reactions.

Following a successful Type B end-of-phase 2 meeting, the FDA has approved the start of a phase 3 trial of linperlisib in peripheral T-cell lymphoma. The FDA has granted clearance to initiate a global ...